Prestige Biologics Co (XKRX:334970) EV-to-Revenue : 168.61 (As of Jun. 17, 2024)

Prestige Biologics Co EV-to-Revenue Chart

Prestige Biologics Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															18,487.85	6,032.21	417.17	227.43	181.55

Competitive Comparison of Prestige Biologics Co's EV-to-Revenue

For the Biotechnology subindustry, Prestige Biologics Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prestige Biologics Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Prestige Biologics Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Prestige Biologics Co's EV-to-Revenue falls into.

Prestige Biologics Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Prestige Biologics Co's EV-to-Revenue for today is calculated as:

Prestige Biologics Co's current Enterprise Value is ₩388,486 Mil.
Prestige Biologics Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,304 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prestige Biologics Co  (XKRX:334970) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Prestige Biologics Co's PS Ratiofor today is calculated as:

Prestige Biologics Co's share price for today is ₩4150.00.
Prestige Biologics Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩37.69.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prestige Biologics Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Prestige Biologics Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige Biologics Co (XKRX:334970) Business Description